Viewing Study NCT00366002


Ignite Creation Date: 2025-12-25 @ 4:05 AM
Ignite Modification Date: 2026-01-22 @ 2:51 PM
Study NCT ID: NCT00366002
Status: COMPLETED
Last Update Posted: 2008-01-15
First Post: 2006-08-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder
Sponsor: Novartis
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CDAR328A2404
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: External Affairs
Old Organization: Novartis

Collaborators

Collaborators

Name Class View
None INDUSTRY View